Development of an alpha v beta 6 integrin selective oncolytic virotherapy based on the low seroprevalence human adenovirus, HAdV-D10.E. A. Bates,J. A. Davies, J. Vanova,D. Nestic, V. S. Meniel, S. Koushyar,T. G. Cunliffe,R. M. Mundy, E. Moses,H. K. Uusi-Kerttula,A. T. Baker,D. K. Cole,D. Majhen,P. J. Rizkallah,T. Phesse,J. D. Chester,A. L. ParkerHUMAN GENE THERAPY（2022）引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
